Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
References (417)
- et al.
Cell. Immunol.
(1982) Cell
(1981)- et al.
Adv. Cancer Res.
(1975) - et al.
Immunol. Today
(1983) - et al.
Cell Immunol.
(1977) - et al.
Lancet
(1975) - et al.
J. Virol.
(1984) - et al.
J. Exp. Med.
(1983)
Immunol. Rev.
Immunogenetics
Immunogenetics
Nature (London)
J. Immunol.
Fed. Proc. Fed. Am. Soc. Exp. Biol.
Transplantation
Eur. J. Immunol.
Immunology
Transplant. Proc.
Transplant. Proc.
Immunogenetics
Genet. Res.
J. Exp. Med.
J. Exp. Med.
Science
J. Cell Biol.
J. Immunol.
Science
Nature (London)
J. Exp. Med.
Nature (London)
J. Immunol.
J. Exp. Med.
Nature (London)
J. Exp. Med.
Proc. Natl. Acad. Sci. U.S.A.
Immunol. Rev.
J. Immunol.
J. Exp. Med.
Br. J. Cancer Suppl. II
Contemp. Top. Immunobiol.
J. Exp. Med.
J. Natl. Cancer Inst.
Immunogenetics
J. Exp. Med.
Nature (London)
Nature (London)
Cited by (178)
Analyses and perspectives in cancer immunotherapy
2006, Biomedicine and PharmacotherapyCitation Excerpt :A number of factors that could influence the outcome of LAK-cell based therapy is subject of debates (see also below). Since it was observed both in animals and in humans, that many tumours elicit an immune response [13–16], efforts are focused on studies concerning the relevant antigen (i.e. tumour associated antigen or TAA) with the hope to mount an anti-tumour rejection reaction. In general, the term of antigen designed a component that triggered an immune response of the organism in contact with it.
The tumor microenvironment in the post-PAGET era
2006, Cancer LettersCitation Excerpt :The interaction of immune components with tumor cells is a case in point. The concept of immune surveillance dominated, and still does, the research trends of cancer immunologists [105–109]. The logical conclusion of this concept is to boost immune responses and employ various forms of immunotherapy [110–122].
Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy
2004, Journal of Thoracic and Cardiovascular SurgeryVaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice
1998, Cellular ImmunologyThe Labyrinthine Ways of Cancer Immunotherapy–T Cell, Tumor Cell Encounter: “How Do I Lose Thee? Let Me Count the Ways”
1998, Advances in Cancer Research